Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study

OBJECTIVE: To assess the 1-year efficacy and safety of a regimen of tocilizumab plus methotrexate or placebo, which was augmented by a treat-to-target strategy from week 24. METHODS: ACT-RAY was a double-blind, 3-year trial. Adults with active rheumatoid arthritis despite methotrexate were randomise...

Descripción completa

Detalles Bibliográficos
Autores principales: Dougados, Maxime, Kissel, Karsten, Conaghan, Philip G, Mola, Emilio Martin, Schett, Georg, Gerli, Roberto, Hansen, Michael Sejer, Amital, Howard, Xavier, Ricardo M, Troum, Orrin, Bernasconi, Corrado, Huizinga, T W J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995223/
https://www.ncbi.nlm.nih.gov/pubmed/24473673
http://dx.doi.org/10.1136/annrheumdis-2013-204761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995223/
https://www.ncbi.nlm.nih.gov/pubmed/24473673
http://dx.doi.org/10.1136/annrheumdis-2013-204761

Ejemplares similares